Literature DB >> 25601525

Dysregulation of microRNA expression in human cervical preneoplastic and neoplastic lesions.

Ádám Galamb1, Márta Benczik, Balázs Zinner, Eszter Vígh, Kornélia Baghy, Csaba Jeney, András Kiss, Gábor Lendvai, Gábor Sobel.   

Abstract

Data discussed in recent reviews demonstrated that dysregulation of microRNA (miRNA) expression profiles occurs during cervical carcinogenesis and characteristic up- or downregulation of certain miRNAs might be used as biomarkers. The majority of altered miRNAs, however were found to be inconsistent upon comparison with cancerous and normal cervical epithelia in the discussed studies due to several reasons. The results obtained in this present review suggest the need for further investigations on miRNAs on larger sample sizes in order to indicate sensitivity and specificity by means of well defined, "unified" methods. In addition, obtaining further data on the clinical course and outcome of patients in comparison to the dysregulation of miRNA expression profile could turn miRNAs into prognostic and/or progression markers. Inhibition of overexpressed miRNAs, as suggested by some authors, might even serve as target for cancer therapy.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25601525     DOI: 10.1007/s12253-014-9871-x

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  44 in total

1.  Dysregulated microRNAs in the pathogenesis and progression of cervical neoplasm.

Authors:  Tak-hong Cheung; Kwun-nok Mimi Man; Mei-yung Yu; So-fan Yim; Nelson S S Siu; Keith W K Lo; Graeme Doran; Raymond R Y Wong; Vivian W Wang; David I Smith; Michael J Worley; Ross S Berkowitz; Tony K H Chung; Yick-fu Wong
Journal:  Cell Cycle       Date:  2012-08-01       Impact factor: 4.534

2.  Unique microRNA expression profiles in cervical cancer.

Authors:  Katalin Gocze; Katalin Gombos; Krisztina Juhasz; Krisztina Kovacs; Bela Kajtar; Marta Benczik; Peter Gocze; Balazs Patczai; Istvan Arany; Istvan Ember
Journal:  Anticancer Res       Date:  2013-06       Impact factor: 2.480

3.  Human papillomavirus type 16 reduces the expression of microRNA-218 in cervical carcinoma cells.

Authors:  I Martinez; A S Gardiner; K F Board; F A Monzon; R P Edwards; S A Khan
Journal:  Oncogene       Date:  2007-11-12       Impact factor: 9.867

4.  Altered MicroRNA expression in cervical carcinomas.

Authors:  Jeong-Won Lee; Chel Hun Choi; Jung-Joo Choi; Young-Ae Park; Seung-Jun Kim; Seung Yong Hwang; Woo Young Kim; Tae-Joong Kim; Je-Ho Lee; Byoung-Gie Kim; Duk-Soo Bae
Journal:  Clin Cancer Res       Date:  2008-05-01       Impact factor: 12.531

5.  MicroRNA-497 is a potential prognostic marker in human cervical cancer and functions as a tumor suppressor by targeting the insulin-like growth factor 1 receptor.

Authors:  Min Luo; Dongxiang Shen; Xiaoning Zhou; Xiaodong Chen; Wei Wang
Journal:  Surgery       Date:  2013-02-28       Impact factor: 3.982

Review 6.  Beyond HPV: oncomirs as new players in cervical cancer.

Authors:  G Reshmi; M Radhakrishna Pillai
Journal:  FEBS Lett       Date:  2008-11-24       Impact factor: 4.124

7.  Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer.

Authors:  O Slaby; M Svoboda; P Fabian; T Smerdova; D Knoflickova; M Bednarikova; R Nenutil; R Vyzula
Journal:  Oncology       Date:  2008-01-15       Impact factor: 2.935

8.  Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth.

Authors:  Xiaohong Wang; Shuang Tang; Shu-Yun Le; Robert Lu; Janet S Rader; Craig Meyers; Zhi-Ming Zheng
Journal:  PLoS One       Date:  2008-07-02       Impact factor: 3.240

9.  Human papillomavirus and cervical cancer.

Authors:  Emma J Crosbie; Mark H Einstein; Silvia Franceschi; Henry C Kitchener
Journal:  Lancet       Date:  2013-04-23       Impact factor: 79.321

10.  MicroRNA-92 regulates cervical tumorigenesis and its expression is upregulated by human papillomavirus-16 E6 in cervical cancer cells.

Authors:  Yu Yu; Yao Zhang; Shulan Zhang
Journal:  Oncol Lett       Date:  2013-06-17       Impact factor: 2.967

View more
  6 in total

1.  Claudin-1 as a Biomarker of Cervical Cytology and Histology.

Authors:  Márta Benczik; Ádám Galamb; Róbert Koiss; Attila Kovács; Balázs Járay; Tamás Székely; Tímea Szekerczés; Zsuzsa Schaff; Gábor Sobel; Csaba Jeney
Journal:  Pathol Oncol Res       Date:  2016-01       Impact factor: 3.201

Review 2.  The Dysregulation of MicroRNAs in the Development of Cervical Pre-Cancer-An Update.

Authors:  Pui-Wah Choi; Tin Lun Liu; Chun Wai Wong; Sze Kei Liu; Yick-Liang Lum; Wai-Kit Ming
Journal:  Int J Mol Sci       Date:  2022-06-27       Impact factor: 6.208

3.  MicroRNA-326 suppresses the proliferation, migration and invasion of cervical cancer cells by targeting ELK1.

Authors:  Ping Zhang; Feng Kong; Xinchao Deng; Yunhai Yu; Congzhe Hou; Tingting Liang; Lin Zhu
Journal:  Oncol Lett       Date:  2017-03-13       Impact factor: 2.967

4.  Detection of high-grade neoplasia in air-dried cervical PAP smears by a microRNA-based classifier.

Authors:  Mikhail K Ivanov; Sergei E Titov; Sergei A Glushkov; Victoria V Dzyubenko; Anastasia V Malek; Polina A Arkhangelskaya; Roman B Samsonov; Andrey A Mikhetko; Elena V Bakhidze; Igor V Berlev; Nikolay N Kolesnikov
Journal:  Oncol Rep       Date:  2018-01-12       Impact factor: 3.906

5.  Plasma expression of miRNA-21, - 214, -34a, and -200a in patients with persistent HPV infection and cervical lesions.

Authors:  Hongyun Wang; Dandan Zhang; Qing Chen; Ying Hong
Journal:  BMC Cancer       Date:  2019-10-23       Impact factor: 4.430

6.  Increased miR-20b Level in High Grade Cervical Intraepithelial Neoplasia.

Authors:  Tímea Szekerczés; Ádám Galamb; Norbert Varga; Márta Benczik; Adrienn Kocsis; Krisztina Schlachter; András Kiss; Nándor Ács; Zsuzsa Schaff; Csaba Jeney; Gábor Lendvai; Gábor Sobel
Journal:  Pathol Oncol Res       Date:  2020-07-08       Impact factor: 3.201

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.